Supernus Pharmaceuticals, Inc.
2019 Q4 - 2025 Q4 (22 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 1/30/2026 | 951 | 0.0% | 19,139 | 12/31/2025 |
| 2025 Q2 | 7/31/2025 | 1,853 | 0.0% | 58,784 | 6/30/2025 |
| 2024 Q4 | 1/31/2025 | 2,136 | 0.0% | 59,081 | 12/31/2024 |
| 2024 Q3 | 11/4/2024 | 1,774 | 0.0% | 56,885 | 9/30/2024 |
| 2024 Q1 | 5/2/2024 | 3,165 | 0.0% | 92,789 | 3/31/2024 |
| 2023 Q4 | 2/2/2024 | 2,685 | 0.0% | 92,789 | 12/31/2023 |
| 2023 Q3 | 11/8/2023 | 2,155 | 0.0% | 78,148 | 9/30/2023 |
| 2023 Q2 | 8/2/2023 | 2,173 | 0.0% | 72,294 | 6/30/2023 |
| 2023 Q1 | 4/26/2023 | 2,181 | 0.0% | 60,189 | 3/31/2023 |
| 2022 Q4 | 2/1/2023 | 2,488 | 0.0% | 69,749 | 12/31/2022 |
| 2022 Q3 | 10/28/2022 | 2,361 | 0.0% | 69,749 | 9/30/2022 |
| 2022 Q2 | 8/4/2022 | 2,391 | 0.0% | 82,668 | 6/30/2022 |
| 2022 Q1 | 5/3/2022 | 2,537 | 0.0% | 78,484 | 3/31/2022 |
| 2021 Q4 | 1/31/2022 | 2,447 | 0.0% | 83,915 | 12/31/2021 |
| 2021 Q3 | 10/27/2021 | 2,983 | 0.0% | 111,845 | 9/30/2021 |
| 2021 Q2 | 7/23/2021 | 2,500 | 0.0% | 81,199 | 6/30/2021 |
| 2021 Q1 | 4/27/2021 | 2,000 | 0.0% | 76,411 | 3/31/2021 |
| 2020 Q4 | 2/3/2021 | 2,685 | 0.0% | 106,724 | 12/31/2020 |
| 2020 Q3 | 10/27/2020 | 2,085 | 0.0% | 100,043 | 9/30/2020 |
| 2020 Q2 | 8/4/2020 | 1,978 | 0.0% | 83,277 | 6/30/2020 |
| 2020 Q1 | 6/19/2020 | 1,805 | 0.0% | 100,340 | 3/31/2020 |
| 2019 Q4 | 1/31/2020 | 2,380 | 0.0% | 100,340 | 12/31/2019 |